Elizabeth Berry, MD, FAAD, reviewed dysplastic nevi as risk markers and highlighted the need for more data on severe cases at AAD 2025.
Elizabeth Berry, MD, FAAD
Advertisement
Elizabeth Berry, MD, FAAD, is an associate professor of dermatology and the director of the Multidisciplinary Melanoma Clinic and the Pigmented Lesions Clinic at Oregon Health and Science University.
Articles by Elizabeth Berry, MD, FAAD
Advertisement
Latest Updated Articles
Mastering Dermoscopy and Dysplastic NeviPublished: March 13th 2025 | Updated:
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
3
Reviewing Type 2 Inflammation Through a Different Lens
4
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
5
